HEART FAILURE WITH PRESERVED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH PRESERVED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH PRESERVED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH PRESERVED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure drug study halted early after only 4 patients
Disease control TerminatedThis early-stage study tested an experimental drug called HS135 in obese people with both heart failure (with preserved pumping ability) and high blood pressure in the lungs. The goal was to check safety and how the drug works in the body. Only 4 patients took part before the stu…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
New heart failure drug trial halted midway – what we know
Disease control TerminatedThis study tested an experimental drug called LY3540378 in adults with worsening chronic heart failure where the heart pumps normally but doesn't fill properly (HFpEF). The goal was to see if the drug could improve heart function and safety. About 332 people were planned to join,…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: PHASE2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 05, 2026 11:55 UTC
-
Heart failure exercise program shows promise, study ends early
Symptom relief TerminatedThis study tested a video-based coaching program to help adults with heart failure exercise regularly. Eleven people took part, and the program offered online exercise classes and access to hospital gyms. The goal was to see if participants could exercise at least 120 minutes per…
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: NA • Sponsor: University of Nebraska • Aim: Symptom relief
Last updated May 15, 2026 11:56 UTC
-
Heart drug study halted: did sex matter?
Knowledge-focused TerminatedThis study tested a drug called PL-3994 in 15 people with a type of heart failure where the heart pumps normally but is stiff. The goal was to see if the drug affects men and women differently. The study was stopped early, so results are limited.
Matched conditions: HEART FAILURE WITH PRESERVED EJECTION FRACTION
Phase: PHASE2 • Sponsor: Palatin Technologies, Inc • Aim: Knowledge-focused
Last updated May 15, 2026 11:55 UTC